Feasibility of recombinant plasmid pEGFP-N1-IGF-1 transfection in an osteoporosis rat

Chen Jian,Chen Yun-zhen,Haichun Liu,Ding Yan,Zhao Hua
DOI: https://doi.org/10.3969/j.issn.1673-8225.2010.33.012
2010-01-01
Abstract:BACKGROUND:The decline of insulin-like growth factor-1(IGF-1) levels has been proven to be an important reason leading to osteoporosis.Gene therapy for osteoporosis and other bone metabolic diseases has becoming a direction of the research,but the viral vector may cause serious immune response.Therefore,the recombinant plasmid pEGFP-N1-IGF-1 in vivo transfection of osteoporosis rats may be a more effective treatment way.OBJECTIVE:To study the IGF-1 expression during recombinant plasmid pEGFP-N1-IGF-1 in the osteoporosis rats in vivo.METHODS:Female Sprague Dawley rats were randomly assigned to sham-surgery group,pEGFP-N1 group and pEGFP-N1-IGF-1 group.Bilateral ovariotomy was performed in pEGFP-N1 group and pEGFP-N1-IGF-1 group.At 12 weeks following surgery,the three groups were given saline,pEGFP-N1 vector and recombinant plasmid pEGFP-N1-IGF-1 complex liposomes hydrodynamic injection,respectively.Fluorescence in vivo imaging and liver biopsy were observed at 48 hours following transfection.Serum concentrations of IGF-1 were determined at regular intervals.RESULTS AND CONCLUSION:After transfection,rats of pEGFP-N1 group and pEGFP-N1-IGF-1 group developed noticeable fluorescence expression not only in the whole body but also liver biopsy,especially in the liver and tail.IGF-1 levels were significantly decreased in rats undergoing ovariotomy(P < 0.05).The expression level of serum IGF-1 in rats of pEGFP-N1-IGF-1 group were significantly increased(P < 0.05),and then reduced over time(P < 0.05).Results indicated that recombinant plasmid pEGFP-N1-IGF-1 can be successfully transfected and expressed IGF-1 protein in osteoporosis rats,which can be a substantial foundation for further application of IGF-1 gene therapy to osteoporosis.
What problem does this paper attempt to address?